These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21102582)

  • 1. Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells.
    Watanabe T; Semba S; Yokozaki H
    Br J Cancer; 2011 Jan; 104(1):146-54. PubMed ID: 21102582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brg1-dependent epigenetic control of vascular smooth muscle cell proliferation by hydrogen sulfide.
    Li L; Liu D; Bu D; Chen S; Wu J; Tang C; Du J; Jin H
    Biochim Biophys Acta; 2013 Jun; 1833(6):1347-55. PubMed ID: 23499876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
    Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
    PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
    Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
    Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brahma is required for cell cycle arrest and late muscle gene expression during skeletal myogenesis.
    Albini S; Coutinho Toto P; Dall'Agnese A; Malecova B; Cenciarelli C; Felsani A; Caruso M; Bultman SJ; Puri PL
    EMBO Rep; 2015 Aug; 16(8):1037-50. PubMed ID: 26136374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
    BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer.
    Ding Y; Li N; Dong B; Guo W; Wei H; Chen Q; Yuan H; Han Y; Chang H; Kan S; Wang X; Pan Q; Wu P; Peng C; Qiu T; Li Q; Gao D; Xue W; Qin J
    J Clin Invest; 2019 Feb; 129(2):759-773. PubMed ID: 30496141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes.
    Sena JA; Wang L; Hu CJ
    Mol Cell Biol; 2013 Oct; 33(19):3849-63. PubMed ID: 23897427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
    Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
    Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.
    Naidu SR; Love IM; Imbalzano AN; Grossman SR; Androphy EJ
    Oncogene; 2009 Jul; 28(27):2492-501. PubMed ID: 19448667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.
    Mehrotra A; Saladi SV; Trivedi AR; Aras S; Qi H; Jayanthy A; Setaluri V; de la Serna IL
    Arch Biochem Biophys; 2014 Dec; 563():125-35. PubMed ID: 25026375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.
    Marty B; Maire V; Gravier E; Rigaill G; Vincent-Salomon A; Kappler M; Lebigot I; Djelti F; Tourdès A; Gestraud P; Hupé P; Barillot E; Cruzalegui F; Tucker GC; Stern MH; Thiery JP; Hickman JA; Dubois T
    Breast Cancer Res; 2008; 10(6):R101. PubMed ID: 19055754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway.
    Shi H; Chen S; Jin H; Xu C; Dong G; Zhao Q; Wang W; Zhang H; Lin W; Zhang J; Davidovic L; Yao L; Fan D
    Cancer Sci; 2009 Sep; 100(9):1585-90. PubMed ID: 19549253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.